BIAF
Price
$1.89
Change
-$0.26 (-12.09%)
Updated
Nov 13, 04:58 PM (EDT)
Capitalization
6.83M
Intraday BUY SELL Signals
TCMD
Price
$24.37
Change
-$0.22 (-0.89%)
Updated
Nov 13 closing price
Capitalization
544.54M
102 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BIAF vs TCMD

Header iconBIAF vs TCMD Comparison
Open Charts BIAF vs TCMDBanner chart's image
bioAffinity Technologies
Price$1.89
Change-$0.26 (-12.09%)
Volume$200
Capitalization6.83M
Tactile Systems Technology
Price$24.37
Change-$0.22 (-0.89%)
Volume$706.79K
Capitalization544.54M
BIAF vs TCMD Comparison Chart in %
BIAF
Daily Signal:
Gain/Loss:
TCMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BIAF vs. TCMD commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIAF is a Hold and TCMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BIAF: $2.15 vs. TCMD: $24.59)
Brand notoriety: BIAF and TCMD are both not notable
BIAF represents the Medical Specialties, while TCMD is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BIAF: 4% vs. TCMD: 111%
Market capitalization -- BIAF: $6.83M vs. TCMD: $544.54M
BIAF [@Medical Specialties] is valued at $6.83M. TCMD’s [@Medical/Nursing Services] market capitalization is $544.54M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $224.77B to $0. The average market capitalization across the [@Medical Specialties] industry is $12.13B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIAF’s FA Score shows that 0 FA rating(s) are green whileTCMD’s FA Score has 1 green FA rating(s).

  • BIAF’s FA Score: 0 green, 5 red.
  • TCMD’s FA Score: 1 green, 4 red.
According to our system of comparison, TCMD is a better buy in the long-term than BIAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIAF’s TA Score shows that 3 TA indicator(s) are bullish while TCMD’s TA Score has 5 bullish TA indicator(s).

  • BIAF’s TA Score: 3 bullish, 4 bearish.
  • TCMD’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TCMD is a better buy in the short-term than BIAF.

Price Growth

BIAF (@Medical Specialties) experienced а -0.92% price change this week, while TCMD (@Medical/Nursing Services) price change was +1.57% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.12%. For the same industry, the average monthly price growth was +1.54%, and the average quarterly price growth was +32.72%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +0.41%. For the same industry, the average monthly price growth was -4.56%, and the average quarterly price growth was +6.50%.

Reported Earning Dates

TCMD is expected to report earnings on Feb 24, 2026.

Industries' Descriptions

@Medical Specialties (+1.12% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (+0.41% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCMD($545M) has a higher market cap than BIAF($6.83M). TCMD YTD gains are higher at: 43.549 vs. BIAF (-92.125). TCMD has higher annual earnings (EBITDA): 29.3M vs. BIAF (-11M). BIAF has less debt than TCMD: BIAF (670K) vs TCMD (42.2M). TCMD has higher revenues than BIAF: TCMD (299M) vs BIAF (7.68M).
BIAFTCMDBIAF / TCMD
Capitalization6.83M545M1%
EBITDA-11M29.3M-38%
Gain YTD-92.12543.549-212%
P/E RatioN/A32.08-
Revenue7.68M299M3%
Total CashN/A96M-
Total Debt670K42.2M2%
FUNDAMENTALS RATINGS
TCMD: Fundamental Ratings
TCMD
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
77
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
2

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIAFTCMD
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BIAF
Daily Signal:
Gain/Loss:
TCMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACOG6.12N/A
N/A
Alpha Cognition Inc
CBU57.12-0.24
-0.42%
Community Financial System Inc
LH266.00-2.21
-0.82%
Laboratory Corp
XTLB0.97-0.02
-2.03%
XTL Biopharmaceuticals Ltd
ARVN10.41-0.80
-7.14%
Arvinas

BIAF and

Correlation & Price change

A.I.dvisor tells us that BIAF and SNWV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIAF and SNWV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIAF
1D Price
Change %
BIAF100%
-0.46%
SNWV - BIAF
32%
Poorly correlated
-5.63%
HSCS - BIAF
29%
Poorly correlated
+2.03%
RDNT - BIAF
26%
Poorly correlated
-5.16%
AORT - BIAF
22%
Poorly correlated
+1.64%
TCMD - BIAF
21%
Poorly correlated
-2.03%
More

TCMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCMD has been loosely correlated with CSTL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TCMD jumps, then CSTL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCMD
1D Price
Change %
TCMD100%
-2.03%
CSTL - TCMD
50%
Loosely correlated
-0.43%
AXGN - TCMD
43%
Loosely correlated
-1.51%
AORT - TCMD
43%
Loosely correlated
+1.64%
OFIX - TCMD
41%
Loosely correlated
-0.52%
GH - TCMD
38%
Loosely correlated
+0.13%
More